Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03379350
Other study ID # 10574
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 26, 2017
Est. completion date May 28, 2021

Study information

Verified date July 2021
Source Beijing Cancer Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

All patients undergo lateral thoracotomy or video-assisted thoracoscopic surgery (VATS) and are operated on by the same thoracic surgical team. All patients are managed with gravity drainage (water seal only, without suction) on the day of operation. Eligible patients are randomized to control group or clamping group at a 1:1 ratio before 3pm on the postoperative day. Patients in control group and those in clamping group are managed with different protocols after 3pm on the postoperative day.


Description:

All patients undergo lateral thoracotomy or video-assisted thoracoscopic surgery (VATS) and are operated on by the same thoracic surgical team. At the end of operation, the lung parenchyma is submerged in sterile saline to test for air leakage, and a single 24-Fr chest tube is placed in each patient. All patients are managed with gravity drainage (water seal only, without suction) on the day of operation. Once a radiograph is confirmed re-expansion of the lung on the morning of the first postoperative day and no air leak is detected, the patient is a candidate for inclusion in the trial. Eligible patients are randomized to control group or clamping group before 3pm on the postoperative day. Patients in control group are managed with gravity drainage unchangeably, while patients in clamping group are managed with clamping protocol after 3pm on the postoperative day as follow: the chest tube will be clamped, and the nurses will check the patient every 6 h. If the patient has no problems with compliance, the clamp will be removed for half an hour in the morning to record the drainage volume every 24 h. If patients develops intolerable abnormal symptoms, such as dyspnea, pneumothorax, and severe subcutaneous emphysema after chest tube clamping, the clamp will be removed for 30 min and be reapplied after the symptoms have been resolved. Such patients will be placed under more rigorous surveillance after re-clamping, which requires the medical staff to check on the patients every 2-4 hours in order to promptly detect abnormal symptoms. If abnormal symptoms occur frequently, this clamping protocol will be continued until another radiograph excluded the presence of pneumothorax. The daily output of pleural fluid was recorded. The criteria for chest tube removal were as follows: (a) drainage volumeā‰¤250 mL in 24 h, (b) absence of air leakage and intrathoracic hemorrhage, and (c) absence of signs of purulent pleural effusion and atelectasis.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date May 28, 2021
Est. primary completion date April 28, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: Pathological diagnosis of lung cancer Treated with lobectomy and systematic mediastinal lymph node dissection/ systematic sampling Managed with gravity drainage (water seal only, without suction) Re-expansion of the lung confirmed on the morning of the first postoperative day Exclusion Criteria: Thoracic cavity infection Prolonged air leakage Reoperation due to chylothorax Atelectasis Liver cirrhosis Renal insufficiency Wound infection

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
clamping group
Clamping group are managed with clamping protocol after 3pm on the postoperative day as follow: the chest tube will be clamped, and the nurses will check the patient every 6 h. If the patient has no problems with compliance, the clamp will be removed for half an hour in the morning to record the drainage volume every 24 h.

Locations

Country Name City State
China Beijing Cancer Hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Wu Nan

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other decrease of hemoglobin level the decrease of hemoglobin on the first postoperative day and before discharge and a month after surgery postoperative day 1, before hosptital discharge and 1 month after the operation
Other decrease of serum albumin level the decrease of serum albumin on the first postoperative day and before discharge and a month after surgery postoperative day 1, before hosptital discharge and 1 month after the operation
Other pleural effusion thickness pleural effusion thickness showed on the CT scan a month after operation observed through CT scan 1 month after the operation
Primary chest tube drainage duration time from operation day to the day of chest tube removal From date of operation until the date of chest tube removal, assessed up to 10 days
Secondary postoperative hospital stay time from opertion day to the day of hospital discharge From date of operation until the date of hospital discharge, assessed up to 2 weeks